Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Groupe francophone thrombose et cancer"'
Autor:
M Jamelot, Corinne Frere, Philippe Debourdeau, L. Buscail, I. Benzidia, A. Hij, B Bournet, Dominique Farge, Groupe francophone thrombose et cancer, H. Rafii-Elayoubi
Publikováno v:
JMV-Journal de Médecine Vasculaire. 43:246-254
Pancreatic cancer (PC) is a devastating malignancy with an overall 5-year survival of 8% for all stages combined. Most of the PC patients diagnosed have an advanced disease (40%) or metastatic stage (40%), which eliminates surgery as a potentially cu
Autor:
pour le Groupe Francophone Thrombose et Cancer, I. Benzidia, Corinne Frere, A Solanilla, M Jamelot, M K Nguessan, U Michon-Pasturel, A. Hij, Dominique Farge, J Connault, C. Le Maignan
Publikováno v:
JMV-Journal de Médecine Vasculaire. 42:375-383
Venous thromboembolism (VTE) is a frequent and serious complication in cancer patients, and the second leading cause of death in this setting. Cancer patients are also more likely to present recurrent VTE and major bleeding while taking anticoagulant
Autor:
Corinne Frere, Manon Lejeune, Pierre Kubicek, Dorothée Faille, Zora Marjanovic, the Groupe Francophone Thrombose et Cancer
Publikováno v:
Cancers
Cancers, MDPI, 2019, 11 (11), pp.1639. ⟨10.3390/cancers11111639⟩
Cancers, Vol 11, Iss 11, p 1639 (2019)
Cancers, MDPI, 2019, 11 (11), pp.1639. ⟨10.3390/cancers11111639⟩
Cancers, Vol 11, Iss 11, p 1639 (2019)
International audience; Over the past two decades, aspirin has emerged as a promising chemoprotective agent to prevent colorectal cancer (CRC). In 2016, the mounting evidence supporting its chemoprotective effect, from both basic science and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf4524093d7e107705548f04ed5c896
https://hal.sorbonne-universite.fr/hal-02426511
https://hal.sorbonne-universite.fr/hal-02426511
Autor:
Dominique Farge, Ludovic Doucet, Christine Le Maignan, Corinne Frere, Groupe francophone thrombose et cancer
Publikováno v:
Thrombosis Research.
This article has been withdrawn at the request of the publisher. The article was submitted for inclusion in the Supplement of full papers from the 8th International Symposium on Women's Health Issues in Thrombosis and Haemostasis (WHITH), to be publi
Publikováno v:
Oncologie. 18:23-31
Les patients traites par chimiotherapie sont a haut risque de maladie thromboembolique veineuse (MTEV) que ce soit embolie pulmonaire (EP) ou thrombose veineuse profonde (TVP). L’evaluation du risque de MTEV est fondee soit sur le score de Khorana,
Publikováno v:
JMV-Journal de Médecine Vasculaire. 43:111-112
Trois anticoagulants oraux directs (AOD) (dabigatran, rivaroxaban et apixaban) sont utilises en France en 2017 avec l’AMM pour le traitement curatif de la maladie thromboembolique veineuse (MTEV) et sa prophylaxie en milieu orthopedique chirurgical
Autor:
Sevestre, Marie-Antoinette, Belizna, Cristina, Durant, Cécile, Bosson, Jean-Luc, Vedrine, L., Cajfinger, F., Debourdeau, P., Farge, D., Carmen Investigators for the Groupe Francophone Thrombose et Cancer, .
Publikováno v:
Journal des Maladies Vasculaires
Journal des Maladies Vasculaires, Elsevier Masson, 2014, 39 (3), pp.161-8. ⟨10.1016/j.jmv.2014.03.001⟩
Journal des Maladies Vasculaires, Elsevier Masson, 2014, 39 (3), pp.161-8. ⟨10.1016/j.jmv.2014.03.001⟩
International audience; Cancer is associated with venous thromboembolism in 20% of patients. In such patients, thrombosis is difficult to treat, associated with bleeding, recurrence, and death. Specific treatments for venous thromboembolism in cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21961c07d9f46fd6c626261a867bc10f
https://hal.univ-angers.fr/hal-03403970
https://hal.univ-angers.fr/hal-03403970
Autor:
Isabelle Mahé, pour le Groupe francophone thrombose et cancer, Francis Cajfinger, P. Debourdeau, M. Marty, D. Farge, Marie-Antoinette Sevestre, A. Long, Cécile Durant
Publikováno v:
Journal des Maladies Vasculaires. 36:82
Autor:
Christophe Dubois, Diane Mege, Walid Ezzedine, Sylvie Cointe, Françoise Dignat-George, Laurence Panicot-Dubois, Estelle Carminita, Stéphane Robert, Nicolas Brouilly, Lydie Crescence, Léa Plantureux
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2020, 80 (2), pp.291-303. ⟨10.1158/0008-5472.CAN-19-1181⟩
Cancer Research, 2020, 80 (2), pp.291-303. ⟨10.1158/0008-5472.CAN-19-1181⟩
Cancer Research, American Association for Cancer Research, 2020, 80 (2), pp.291-303. ⟨10.1158/0008-5472.CAN-19-1181⟩
Cancer Research, 2020, 80 (2), pp.291-303. ⟨10.1158/0008-5472.CAN-19-1181⟩
Platelets promote metastasis, however, their role in tumor growth remains controversial. Here, we investigated the effect of platelet interactions with colorectal tumor cells. Platelets extravasated into the tumor microenvironment and interacted with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04ad7008fc4a62fa722a4726850415c
https://hal-amu.archives-ouvertes.fr/hal-02571104
https://hal-amu.archives-ouvertes.fr/hal-02571104
Autor:
Frere C; INSERM UMRS-1166, Institute of Cardiometabolism and Nutrition, GRC 27 GRECO, Sorbonne Université, DMU BioGem, Pitié-Salpêtrière Hospital, Assistance publique-Hôpitaux de Paris, 75013 Paris, France; Groupe Francophone Thrombose et Cancer, 75015 Paris, France. Electronic address: corinne.frere@aphp.fr., Crichi B; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Internal Medicine Unit (UF 04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Saint-Louis Hospital, Assistance publique-Hôpitaux de Paris, 75010 Paris, France., Rueda-Camino JA; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Department of Internal Medicine, Hospital Rey Juan Carlos, Madrid, Spain., Cajfinger F; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Department of Medical Oncology, Pitié-Salpêtrière Hospital, Assistance publique-Hôpitaux de Paris, 75013 Paris, France., Spiess N; LEO Pharma, 78960 Voisin-le-Bretonneux, France., Janus N; LEO Pharma, 78960 Voisin-le-Bretonneux, France., Le Maignan C; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Department of Internal Medicine, Hospital Rey Juan Carlos, Madrid, Spain., Marjanovic Z; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Department of Hematology, Saint-Antoine Hospital, Assistance publique-Hôpitaux de Paris, 75010 Paris, France., Farge D; Groupe Francophone Thrombose et Cancer, 75015 Paris, France; Internal Medicine Unit (UF 04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Saint-Louis Hospital, Assistance publique-Hôpitaux de Paris, 75010 Paris, France; Université de Paris, Institut Universitaire d'Hématologie, EA 3518, 75010 Paris, France.
Publikováno v:
Journal de medecine vasculaire [J Med Vasc] 2022 Apr; Vol. 47 (2), pp. 56-64. Date of Electronic Publication: 2022 May 20.